39 results
8-K
EX-3.1
ALIM
Alimera Sciences Inc.
15 Aug 23
Unregistered Sales of Equity Securities
4:55pm
8-K
EX-3.1
ALIM
Alimera Sciences Inc.
2 Aug 23
Unregistered Sales of Equity Securities
5:18pm
8-K
EX-3.1
ALIM
Alimera Sciences Inc.
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
DEFA14A
EX-3.3
ALIM
Alimera Sciences Inc.
27 Mar 23
Additional proxy soliciting materials
10:12am
DEFA14A
EX-3.2
ALIM
Alimera Sciences Inc.
27 Mar 23
Additional proxy soliciting materials
10:12am
DEFA14A
EX-3.1
ghuafujq
27 Mar 23
Additional proxy soliciting materials
10:12am
8-K
EX-3.1
k0pr98g3jmyc4xq7z4
27 Mar 23
Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility
10:06am
8-K
EX-3.3
i9r6e0
27 Mar 23
Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility
10:06am
8-K
EX-3.2
uaqs4xn 46ak1b
27 Mar 23
Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility
10:06am
8-K
EX-3.2
mnm68bjd6
14 Nov 19
Alimera Sciences Announces Effectiveness
5:02pm
8-K
EX-3.3
2z6qu3spd tstni
16 Sep 19
Amendments to Articles of Incorporation or Bylaws
5:25pm
8-K
EX-3.1
958 35qdoeck0hd
5 Sep 18
Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock
12:00am
8-K
EX-3.2
h2383kv5oj37itz
5 Sep 18
Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock
12:00am
8-K
EX-3.1
652c4mn
5 Nov 15
Alimera Sciences Reports Third Quarter 2015 Financial Results
12:00am
8-K
EX-3.6
3e4 g4cuyhug
15 Dec 14
Alimera Sciences Announces Closing of $50.0 Million Financing with Deerfield Management
12:00am
8-K
EX-3.6
bs4b2lw k775kp
28 Nov 14
Alimera Sciences Announces Agreement with Deerfield Management
12:00am